Three weeks of SSRI administration enhances the visual perceptual threshold: a randomized placebo-controlled study
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Three weeks of SSRI administration enhances the visual perceptual threshold : a randomized placebo-controlled study. / Lansner, Jon; Jensen, Christian Gaden; Petersen, Anders; Fisher, Patrick M.; Frokjaer, Vibe G.; Vangkilde, Signe Allerup; Knudsen, Gitte Moos.
In: Psychopharmacology, Vol. 236, No. 6, 2019, p. 1759–1769.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Three weeks of SSRI administration enhances the visual perceptual threshold
T2 - a randomized placebo-controlled study
AU - Lansner, Jon
AU - Jensen, Christian Gaden
AU - Petersen, Anders
AU - Fisher, Patrick M.
AU - Frokjaer, Vibe G.
AU - Vangkilde, Signe Allerup
AU - Knudsen, Gitte Moos
PY - 2019
Y1 - 2019
N2 - Rationale: The serotonergic system has been repeatedly linked to visual attention in general, but the effects of selective serotonin reuptake inhibitor (SSRI) on specific components of visual attention remain unknown. Changes in distinct perceptual and cognitive processes are not readily evident in most attention paradigms. Objective: In this study, we isolate basic components of visual attention to investigate potential effects of longer-term SSRI administration on non-emotional aspects of visual attention in healthy males. Methods: In a randomized double-blind placebo-controlled design, 32 young healthy males were tested on multiple attentional parameters, before and after a 3-week SSRI intervention with fluoxetine (40 mg daily) or placebo. Data were modeled with a computational theory of visual attention to derive independent estimates of five distinct components of visual attention. Results: The SSRI intervention selectively and significantly lowered the threshold for conscious visual perception. Specifically, we demonstrate that this improvement does not stem from a general increase in the speed of visual processing, as previously suggested, but specifically from a change in the perceptual threshold. Conclusions: The study provides a novel description of the attentional dynamics affected by SSRI, while supporting previous findings on attentional effects of SSRI. Furthermore, it accentuates the utility of employing accuracy-based measures of attentional performance when conducting psychopharmacological research.
AB - Rationale: The serotonergic system has been repeatedly linked to visual attention in general, but the effects of selective serotonin reuptake inhibitor (SSRI) on specific components of visual attention remain unknown. Changes in distinct perceptual and cognitive processes are not readily evident in most attention paradigms. Objective: In this study, we isolate basic components of visual attention to investigate potential effects of longer-term SSRI administration on non-emotional aspects of visual attention in healthy males. Methods: In a randomized double-blind placebo-controlled design, 32 young healthy males were tested on multiple attentional parameters, before and after a 3-week SSRI intervention with fluoxetine (40 mg daily) or placebo. Data were modeled with a computational theory of visual attention to derive independent estimates of five distinct components of visual attention. Results: The SSRI intervention selectively and significantly lowered the threshold for conscious visual perception. Specifically, we demonstrate that this improvement does not stem from a general increase in the speed of visual processing, as previously suggested, but specifically from a change in the perceptual threshold. Conclusions: The study provides a novel description of the attentional dynamics affected by SSRI, while supporting previous findings on attentional effects of SSRI. Furthermore, it accentuates the utility of employing accuracy-based measures of attentional performance when conducting psychopharmacological research.
KW - 5-HT
KW - Attention
KW - Cognition
KW - Healthy
KW - Human
KW - Non-motor
KW - Perception
KW - Serotonin
KW - SSRI
KW - Theory of visual attention
KW - TVA
KW - Unspeeded response
U2 - 10.1007/s00213-018-5158-3
DO - 10.1007/s00213-018-5158-3
M3 - Journal article
C2 - 30623228
AN - SCOPUS:85059777952
VL - 236
SP - 1759
EP - 1769
JO - Psychopharmacology
JF - Psychopharmacology
SN - 0033-3158
IS - 6
ER -
ID: 215927754